USFDA completes audit of Dr. Reddy’s Andhra Pradesh facility
The US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy’s Laboratories’ Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on November 16, 2018 with zero observations.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.